Capricor Therapeutics
CAPR
#7633
Rank
ยฃ0.33 B
Marketcap
ยฃ5.80
Share price
0.80%
Change (1 day)
32.12%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): -ยฃ1.84

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ1.87. In 2025 the company made an earnings per share (EPS) of -ยฃ1.73 a decrease over its 2024 EPS that were of -ยฃ0.92.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.846.27%
2025-ยฃ1.7388.33%
2024-ยฃ0.92
2022-ยฃ0.9035.63%
2021-ยฃ0.67-7.45%
2020-ยฃ0.72-55.45%
2019-ยฃ1.61-59.81%
2018-ยฃ4.01-1850%
2017ยฃ0.23-102.94%
2016-ยฃ7.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.11-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.33-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ4.62 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.33 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ5.77 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ22.39 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA